Form 4: IGM Biosciences CEO Sells Shares to Cover Tax Obligations
SEC Form 4
IGM Biosciences CEO Mary Beth Harler sold 7,329 shares of common stock on March 14, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 14, 2025, Mary Beth Harler, CEO of IGM Biosciences, sold 7,329 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $1.23, with individual trades ranging from $1.19 to $1.28.
- Following the transaction, Harler directly owns 339,703 shares of IGM Biosciences common stock.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (stock sale for tax obligations) by the CEO, which is neither particularly positive nor negative. It's a neutral event in terms of investment sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of stock sale transaction. |
| 03/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.